Inhibitors of H2-Kd are a class of compounds that function by interfering with the processes that H2-Kd is involved in, rather than directly inhibiting the protein itself. They can be categorized based on their mechanism of action and their target within the cell. H2-Kd inhibitors function by inhibiting calcineurin, a phosphatase that dephosphorylates NFAT and reduces its nuclear translocation, indirectly affecting antigen presentation by H2-Kd. Other inhibitors work by inhibiting mTOR, a master regulator of cell growth and proliferation, which can indirectly affect antigen presentation by H2-Kd.
Several of H2-Kd inhibitors function by inhibiting protein trafficking or disrupting cellular compartments. H2-Kd inhibitors function by inhibiting protein trafficking from the endoplasmic reticulum to the Golgi apparatus, which can affect the presentation of antigens by H2-Kd. Additionally, inhibitors can also disrupt Golgi function and can impede the movement of MHC molecules like H2-Kd to the cell surface. Other inhibitors function by interfering with protein synthesis or degradation. These compounds can affect the production of H2-Kd and its associated antigenic peptides, as well as the processing of antigens for presentation by H2-Kd. In addition, inhibitors function by interfering with DNA replication and transcription, which can affect the expression of H2-Kd.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis, which can affect the production of H2-Kd and its associated antigenic peptides. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is a folate antagonist that can interfere with DNA synthesis, potentially affecting the expression of H2-Kd. | ||||||